Marker Therapeutics, Inc. (MRKR) Social Stream



Marker Therapeutics, Inc. (MRKR): $1.92

0.20 (+11.63%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add MRKR to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#412 of 449

in industry

MARKER THERAPEUTICS INC (MRKR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MARKER THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $8 $5.5 $6.375 $1.84 246.47%
2022-02-04 4 $8 $3 $5.625 $1.84 205.71%
2022-02-23 4 $6 $1 $4 $1.84 117.39%
2022-03-18 4 $5 $1 $3.75 $1.84 103.8%
2022-05-13 4 $5 $1 $3.625 $1.84 97.01%
2022-05-16 1 $40 $40 $40 $1.84 2073.91%
2022-08-11 4 $5 $1 $2.875 $1.84 56.25%
2022-11-10 3 $4 $1 $2.166 $1.84 17.72%

Price Target Last Issued May 16, 2022

The Trend in the Analyst Price Target


MRKR's average price target has moved down $4.5 over the prior 22 months.

MRKR reports an average of 486.85% for its upside potential over the past 91 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-11 4 4 1 2.166 0.449 382.41%
2022-08-11 4 5 1 2.875 0.449 540.31%
2022-11-10 2 4 1 2.166 0.381 468.5%
2022-11-10 3 4 1 2.500 0.381 556.17%
2022-11-10 3 4 1 2.166 0.381 468.5%

MRKR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


MRKR's average broker recommendation rating improved by 0.08 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRKR as an investment opportunity.

  • MRKR has a higher average analyst price target than 71.72% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, MARKER THERAPEUTICS INC's variance in analysts' estimates is lower than -673.78% of them.
  • In the context of Healthcare stocks, MARKER THERAPEUTICS INC's number of analysts covering the stock is higher than 143.05% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MARKER THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 504.43% of them.

Stocks similar to MARKER THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGLE, NMTR, and SYBX.

Is MRKR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6747 seconds.